Cavitation Technologies reports $0 revenue and $208,000 net loss
- Form
- 10-Q
- Filed
- Importance
- Notable
- Accession
- 0001683168-26-008112
- Revenue: $0 for the three months ended Sep 30, 2026
- Net loss: $208,000 for the three months ended Sep 30, 2026
- Cash and equivalents: $94,000 at Sep 30, 2026
Written from the 10-Q on EDGAR. Check the filing before you rely on it.
What changed since last quarter
Compared with the 10-Q for the period ended Mar 31, 2026.
| This filing | Previous | Change vs prior 10-Q | |
|---|---|---|---|
| Revenue | $0 | −$3K | +100% |
| Operating income and margin | −$165K | −$434K | +62% |
| Net income | −$208K | −$451K | +54% |
| Operating cash flow | −$128K | −$228K | +44% |
| Cash | $94K | $17K | +453% |
Similar companies
Companies of similar size in SIC 700 and related industry codes: the same peer list as the financial tables.
- RYTHM RYM public float $27M, Jun 30, 2025
- Chase Packaging WHLT public float $4M, Jun 30, 2025
- BNB Standard BNC public float $324M, Oct 31, 2025
- Mission Produce AVO public float $496M, Apr 30, 2025, over 18 months old
- Calavo Growers CVGW public float $500M, Apr 30, 2025, over 18 months old